Relyea Zuckerberg Hanson LLC Sells 42 Shares of Cigna Group $CI

Relyea Zuckerberg Hanson LLC lowered its stake in shares of Cigna Group (NYSE:CIFree Report) by 3.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,165 shares of the health services provider’s stock after selling 42 shares during the quarter. Relyea Zuckerberg Hanson LLC’s holdings in Cigna Group were worth $385,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Flaharty Asset Management LLC acquired a new position in Cigna Group in the 1st quarter valued at $28,000. 1248 Management LLC bought a new stake in Cigna Group during the first quarter valued at about $29,000. Activest Wealth Management grew its position in shares of Cigna Group by 360.0% in the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 72 shares during the last quarter. Retirement Wealth Solutions LLC increased its stake in shares of Cigna Group by 74.1% in the second quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock worth $33,000 after purchasing an additional 43 shares during the period. Finally, Saudi Central Bank acquired a new position in shares of Cigna Group during the 1st quarter worth about $36,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Guggenheim reaffirmed a “buy” rating and issued a $350.00 target price (down previously from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Wall Street Zen lowered shares of Cigna Group from a “buy” rating to a “hold” rating in a research report on Friday. Cantor Fitzgerald reissued an “overweight” rating and issued a $365.00 price target on shares of Cigna Group in a report on Tuesday, August 26th. TD Cowen raised shares of Cigna Group to a “strong-buy” rating in a research report on Monday, June 23rd. Finally, Barclays increased their target price on shares of Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $371.81.

View Our Latest Stock Report on Cigna Group

Cigna Group Stock Down 2.5%

NYSE CI opened at $303.30 on Tuesday. Cigna Group has a 1-year low of $256.89 and a 1-year high of $358.88. The company has a market capitalization of $80.96 billion, a price-to-earnings ratio of 16.56, a PEG ratio of 0.91 and a beta of 0.45. The stock’s 50 day moving average is $292.64 and its two-hundred day moving average is $309.56. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. During the same quarter in the previous year, the firm earned $6.72 EPS. Cigna Group’s quarterly revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were given a dividend of $1.51 per share. The ex-dividend date was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group’s dividend payout ratio (DPR) is 32.97%.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.70% of the stock is owned by corporate insiders.

About Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.